Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

2(50.0%)

Phase 3

1(25.0%)

Phase 2

1(25.0%)

4Total

N/A(2)

Phase 3(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT00614796Not ApplicableCompleted

A Structured Lifestyle Intervention on Daily Physical Activity Level in COPD

Role: lead

NCT00452764Completed

Regulatory T Cells in COPD

Role: lead

NCT00135538Phase 3Unknown

The Additional Value of Noninvasive Ventilation Next to Rehabilitation in Hypercapnic COPD Patients

Role: lead

NCT00116311Unknown

Effects of Allergen Inhalation on Adenosine Receptor Expression in Sputum and Peripheral Blood

Role: lead

NCT00224432Not ApplicableCompleted

Double-Blind, Parallel, Randomised Study to Investigate the Effect of Oral Probiotics in Infants With Atopic Dermatitis

Role: lead

NCT00122694Phase 2Completed

Modification of Chronic Inflammation by Inhaled Carbon Monoxide in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD)

Role: lead

All 6 trials loaded